Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 27, 2023
Impact of Single-Time-Point Estimates of <sup>177</sup>Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles
Alexandre Chicheportiche, Moshe Sason, Mahmoud Zidan, et al.
EJNMMI Physics
|
February 13, 2021
Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in <sup>68</sup>Ga-DOTATATE PET/CT studies?
Alexandre Chicheportiche, Elinor Goshen, Jeremy Godefroy, et al.
International Immunopharmacology
|
January 23, 2003
Linomide inhibits insulitis and modulates cytokine production in pancreatic islets in the nonobese diabetic mouse
Eva Dahlén, Kim Dawe, Lennart Ohlsson, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 7, 2018
Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study
Dania Hirsch, Orit Twito, Sigal Levy, et al.
Cancer
|
March 23, 2011
Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas
Simona Grozinsky-Glasberg, Dganit Barak, Merav Fraenkel, et al.
Archives of Pathology & Laboratory Medicine
|
January 24, 2020
The State of the Job Market for Pathologists: Evidence From the College of American Pathologists Practice Leader Survey
David J Gross, W Stephen Black-Schaffer, Robert D Hoffman, et al.
EJNMMI Physics
|
August 26, 2021
Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
Alexandre Chicheportiche, Moshe Sason, Jeremy Godefroy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 13, 2017
Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
Endocrine-Related Cancer
|
May 27, 2006
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R
David J Gross, Gabriel Munter, Menachem Bitan, et al.
Molecular Imaging and Biology
|
July 24, 2010
68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: comparison with ¹¹¹In-DTPA-octreotide (OctreoScan®)
Yodphat Krausz, Nanette Freedman, Rina Rubinstein, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 27, 2023
Impact of Single-Time-Point Estimates of <sup>177</sup>Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles
Alexandre Chicheportiche, Moshe Sason, Mahmoud Zidan, et al.
EJNMMI Physics
|
February 13, 2021
Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in <sup>68</sup>Ga-DOTATATE PET/CT studies?
Alexandre Chicheportiche, Elinor Goshen, Jeremy Godefroy, et al.
International Immunopharmacology
|
January 23, 2003
Linomide inhibits insulitis and modulates cytokine production in pancreatic islets in the nonobese diabetic mouse
Eva Dahlén, Kim Dawe, Lennart Ohlsson, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 7, 2018
Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study
Dania Hirsch, Orit Twito, Sigal Levy, et al.
Cancer
|
March 23, 2011
Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas
Simona Grozinsky-Glasberg, Dganit Barak, Merav Fraenkel, et al.
Archives of Pathology & Laboratory Medicine
|
January 24, 2020
The State of the Job Market for Pathologists: Evidence From the College of American Pathologists Practice Leader Survey
David J Gross, W Stephen Black-Schaffer, Robert D Hoffman, et al.
EJNMMI Physics
|
August 26, 2021
Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
Alexandre Chicheportiche, Moshe Sason, Jeremy Godefroy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 13, 2017
Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
Endocrine-Related Cancer
|
May 27, 2006
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R
David J Gross, Gabriel Munter, Menachem Bitan, et al.
Molecular Imaging and Biology
|
July 24, 2010
68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: comparison with ¹¹¹In-DTPA-octreotide (OctreoScan®)
Yodphat Krausz, Nanette Freedman, Rina Rubinstein, et al.
Page
of 8